Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era.

Expert Rev Anti Infect Ther 2014 May 1;12(5):549-54. Epub 2014 Apr 1.

Infectious Disease Service, Veterans Affairs Medical Center, 2101 Elm Street N, Fargo, ND 58102, USA.

In the era of multidrug resistance, it is critical to utilize antibiotics in an appropriate manner and to identify new treatments or revisit the use of 'forgotten' drugs. Because urinary tract infections (UTIs) are common, particularly in an increasing elderly population, the 'forgotten' drug, methenamine, may become important as a preventive therapy for recurrent UTIs. Methenamine, a urinary antibacterial agent, can be used as methenamine hippurate or methenamine mandelate preparations and is United States Food and Drug Administration-approved. This article discusses the place of preventive therapy for recurrent UTIs, chemistry, mechanism of action, pharmacology, clinical uses, dosage, adverse reactions and safety, and drug interactions of methenamine. Because of its unique antiseptic property, the authors suggest that methenamine should be considered when more commonly used antibiotics fail to suppress recurrent UTIs.

Download full-text PDF

Source
http://dx.doi.org/10.1586/14787210.2014.904202DOI Listing
May 2014

Publication Analysis

Top Keywords

recurrent utis
12
urinary tract
8
multidrug resistance
8
preventive therapy
8
therapy recurrent
8
methenamine
7
mandelate preparations
4
methenamine mandelate
4
article discusses
4
administration-approved article
4
preparations united
4
food drug
4
hippurate methenamine
4
drug administration-approved
4
united states
4
states food
4
antibacterial agent
4
drug methenamine
4
'forgotten' drug
4
population 'forgotten'
4

Similar Publications